Our Work in HIV

Since the first HIV products became available nearly three decades ago, we have worked to expand access to our medicines, build healthcare infrastructure, and address health and development challenges around the world.

WORLDWIDE

Approximately 36.7 MILLION people were living with HIV at the end of 2016

Approximately 1.8 MILLION people became newly infected with HIV in 2016

%

It is estimated that currently only 70% of people with HIV know their status

IT TAKES A MULTIFACETED APPROACH TO IMPROVE ACCESS

We continue to explore ways to enhance access to our HIV medicines, particularly in the developing world, and through partnerships that seek to strengthen health systems to better deliver prevention and treatment services. Clearly, the need is too great for any one stakeholder to address, requiring coordinated efforts among many. We are committed to working with governments, donors, innovative and generic manufacturers, multilateral organizations and civil society to address the full range of factors affecting access.

LEARN MORE